6533b837fe1ef96bd12a1de7
RESEARCH PRODUCT
A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care
Richard E. KastWeiguang WangKalkunte S. SrivenugopalJohn A. BoockvarWen-wei ChangAlireza KhoshnevisanMarco TuccoriKirsi KetolaMarc Eric HalatschBoris CvekNicolas MagnéSeyed H. GhaffariAvishay SellaGeorg Karpel-masslerDaniele FocosiChristian Rainer WirtzMohammad H. PourgholamiAmeya ParanjpeChristine MarosiKerrie L. McdonaldAnsgar BrüningMiguel MuñozDaniel KeizmanFrancesco CappelloThomas EfferthIacopo SardiQ. Ping DouAlfonso Dueñas-gonzálezsubject
medicine.medical_specialtyCaptoprilTel avivMorpholinesArtesunateReviewGluconatesAngiotensinQuality of lifeAuranofinSertralineAntineoplastic Combined Chemotherapy ProtocolsDisulfiramTemozolomidemedicineRecurrent diseaseHumansIn patientNelfinavirTemozolomideBrain Neoplasmsbusiness.industrySuccinatesNeurokininCytotoxic chemotherapyUniversity hospitalmedicine.diseaseArtemisininsSurgeryDacarbazineKetoconazoleOncologyangiotensin aprepitant artesunate auranofin captopril cytokines disulfiram glioblastoma ketoconazole nelfinavir neurokinin sertraline temozolomideFamily medicineCytokinesNeoplasm Recurrence LocalGlioblastomabusinessAprepitantGlioblastomamedicine.drugdescription
Kast, Richard E. et al.
year | journal | country | edition | language |
---|---|---|---|---|
2013-01-01 | Oncotarget |